Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II)-Reference-Cited by-同舟云学术

Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II)

Published:2020-06 Issue:3 Volume:30 Page:261-267
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Atkinson Victoria,Sandhu Shahneen,Hospers Geke,Long Georgina V.,Aglietta Massimo,Ferrucci Pier F.,Tulyte Skaiste,Cappellini Gian Carlo Antonini,Soriano Virtudes,Ali Sayed,Poprach Alexandr,Cesas Alvydas,Rodriguez-Abreu Delvys,Lau Mike,de Jong Egbert,Legenne Philippe,Stein Dara,King Brianna,van Thienen Johannes V.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference19 articles.

1. Major changes in systemic therapy for advanced melanoma.;Thompson;J Natl Compr Canc Netw,2016

2. Mutations of the BRAF gene in human cancer.;Davies;Nature,2002

3. Pembrolizumab versus ipilimumab in advanced melanoma.;Robert;N Engl J Med,2015

4. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma.;Larkin;N Engl J Med,2015

5. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial.;Hauschild;Lancet,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving cancer stem cells killing in malignant melanoma;British Journal of Dermatology;2024-01-29

2. Effectiveness Treatment of a BRAF-ZKSCAN5 Fusion Gene Melanoma Case with Dabrafenib/Trametinib;Case Reports in Oncology;2023-09-22

3. COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma;Cancers;2023-09-06

4. Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapies;2023-08-03

5. Outcomes in patients with BRAF^V600–mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib;Tumori Journal;2023-07-07